These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Hirasawa A; Sugawara T; Awaji T; Tsumaya K; Ito H; Tsujimoto G Mol Pharmacol; 1997 Nov; 52(5):764-70. PubMed ID: 9351966 [TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP-mediated upregulation of the expression of neuronal NO synthase in human A673 neuroepithelioma cells results in a decrease in the level of bioactive NO production: analysis of the signaling mechanisms that are involved. Boissel JP; Bros M; Schröck A; Gödtel-Armbrust U; Förstermann U Biochemistry; 2004 Jun; 43(22):7197-206. PubMed ID: 15170357 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide inhibition of ERK1/2 activity in cells expressing neuronal nitric-oxide synthase. Raines KW; Cao GL; Porsuphatana S; Tsai P; Rosen GM; Shapiro P J Biol Chem; 2004 Feb; 279(6):3933-40. PubMed ID: 14602725 [TBL] [Abstract][Full Text] [Related]
14. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries. Lekontseva O; Chakrabarti S; Jiang Y; Cheung CC; Davidge ST J Pharmacol Exp Ther; 2011 Nov; 339(2):367-75. PubMed ID: 21807885 [TBL] [Abstract][Full Text] [Related]
15. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells. Zhong H; Minneman KP Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878 [TBL] [Abstract][Full Text] [Related]
16. alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. Kameya S; Miyagoe Y; Nonaka I; Ikemoto T; Endo M; Hanaoka K; Nabeshima Y; Takeda S J Biol Chem; 1999 Jan; 274(4):2193-200. PubMed ID: 9890982 [TBL] [Abstract][Full Text] [Related]
17. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation. Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059 [TBL] [Abstract][Full Text] [Related]
18. Binding of neuronal nitric-oxide synthase (nNOS) to carboxyl-terminal-binding protein (CtBP) changes the localization of CtBP from the nucleus to the cytosol: a novel function for targeting by the PDZ domain of nNOS. Riefler GM; Firestein BL J Biol Chem; 2001 Dec; 276(51):48262-8. PubMed ID: 11590170 [TBL] [Abstract][Full Text] [Related]
19. Trophic effects induced by alpha1D-adrenoceptors on endothelial cells are potentiated by hypoxia. Vinci MC; Bellik L; Filippi S; Ledda F; Parenti A Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2140-7. PubMed ID: 17660397 [TBL] [Abstract][Full Text] [Related]
20. The Ras-ERK pathway is required for the induction of neuronal nitric oxide synthase in differentiating PC12 cells. Schonhoff CM; Bulseco DA; Brancho DM; Parada LF; Ross AH J Neurochem; 2001 Aug; 78(3):631-9. PubMed ID: 11483666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]